Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome
-
- Daniela Weiskopf
- Center for Infectious Disease, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
-
- Katharina S. Schmitz
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
-
- Matthijs P. Raadsen
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
-
- Alba Grifoni
- Center for Infectious Disease, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
-
- Nisreen M. A. Okba
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
-
- Henrik Endeman
- Department of Intensive Care, Erasmus MC, Rotterdam, the Netherlands.
-
- Johannes P. C. van den Akker
- Department of Intensive Care, Erasmus MC, Rotterdam, the Netherlands.
-
- Richard Molenkamp
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
-
- Marion P. G. Koopmans
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
-
- Eric C. M. van Gorp
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
-
- Bart L. Haagmans
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
-
- Rik L. de Swart
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
-
- Alessandro Sette
- Center for Infectious Disease, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
-
- Rory D. de Vries
- Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
説明
<jats:p> Peptide pool stimulation enables longitudinal analysis of SARS-CoV-2–specific CD4 <jats:sup>+</jats:sup> and CD8 <jats:sup>+</jats:sup> T cells in ICU-admitted COVID-19 patients. </jats:p>
収録刊行物
-
- Science Immunology
-
Science Immunology 5 (48), eabd2071-, 2020-06-26
American Association for the Advancement of Science (AAAS)